GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (FRA:CYL) » Definitions » Institutional Ownership

Artivion (FRA:CYL) Institutional Ownership : 60.30% (As of Apr. 29, 2025)


View and export this data going back to . Start your Free Trial

What is Artivion Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Artivion's institutional ownership is 60.30%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Artivion's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Artivion's Float Percentage Of Total Shares Outstanding is 79.51%.


Artivion Institutional Ownership Historical Data

The historical data trend for Artivion's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artivion Institutional Ownership Chart

Artivion Historical Data

The historical data trend for Artivion can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 57.03 57.81 58.27 55.80 56.09 56.63 58.98 59.63 59.56 60.30

Artivion Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Artivion Business Description

Traded in Other Exchanges
Address
1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Artivion Headlines

No Headlines